The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease

John T. Patton(The Ohio State University), Robert A. Baiocchi(The Ohio State University)
Oncotarget
June 12, 2014
Cited by 28


Related Papers